These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10812286

  • 1. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
    Greenwald MK, Stitzer ML.
    Drug Alcohol Depend; 2000 Jun 01; 59(3):261-75. PubMed ID: 10812286
    [Abstract] [Full Text] [Related]

  • 2. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M, Bisaga A, Foltin RW.
    Psychopharmacology (Berl); 2003 Feb 01; 166(1):77-85. PubMed ID: 12491025
    [Abstract] [Full Text] [Related]

  • 3. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
    Wachtel SR, de Wit H.
    Drug Alcohol Depend; 2000 Jun 01; 59(3):251-60. PubMed ID: 10812285
    [Abstract] [Full Text] [Related]

  • 4. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
    Cooper ZD, Haney M.
    Psychopharmacology (Berl); 2010 Aug 01; 211(2):141-8. PubMed ID: 20490465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Marijuana's dose-dependent effects in daily marijuana smokers.
    Ramesh D, Haney M, Cooper ZD.
    Exp Clin Psychopharmacol; 2013 Aug 01; 21(4):287-93. PubMed ID: 23937597
    [Abstract] [Full Text] [Related]

  • 7. Effects of oral THC maintenance on smoked marijuana self-administration.
    Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW.
    Drug Alcohol Depend; 2002 Aug 01; 67(3):301-9. PubMed ID: 12127201
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H.
    Psychopharmacology (Berl); 2002 Jun 01; 161(4):331-9. PubMed ID: 12073159
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
    Cooper ZD, Comer SD, Haney M.
    Neuropsychopharmacology; 2013 Sep 01; 38(10):1984-92. PubMed ID: 23609132
    [Abstract] [Full Text] [Related]

  • 11. Effects of acute smoked marijuana on complex cognitive performance.
    Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW.
    Neuropsychopharmacology; 2001 Nov 01; 25(5):757-65. PubMed ID: 11682259
    [Abstract] [Full Text] [Related]

  • 12. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
    Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM.
    J Pharmacol Exp Ther; 1992 Apr 01; 261(1):114-22. PubMed ID: 1313866
    [Abstract] [Full Text] [Related]

  • 13. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
    Heishman SJ, Stitzer ML, Yingling JE.
    Pharmacol Biochem Behav; 1989 Sep 01; 34(1):173-9. PubMed ID: 2560548
    [Abstract] [Full Text] [Related]

  • 14. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
    Hunault CC, Böcker KB, Stellato RK, Kenemans JL, de Vries I, Meulenbelt J.
    Psychopharmacology (Berl); 2014 Dec 01; 231(24):4723-33. PubMed ID: 24879495
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of alcohol and marijuana on mood, memory, and performance.
    Heishman SJ, Arasteh K, Stitzer ML.
    Pharmacol Biochem Behav; 1997 Sep 01; 58(1):93-101. PubMed ID: 9264076
    [Abstract] [Full Text] [Related]

  • 16. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Sarne Y, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E.
    J Psychopharmacol; 2008 Jun 01; 22(4):441-51. PubMed ID: 18635724
    [Abstract] [Full Text] [Related]

  • 17. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW.
    Neuropsychopharmacology; 2004 Jan 01; 29(1):158-70. PubMed ID: 14560320
    [Abstract] [Full Text] [Related]

  • 18. The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.
    Justinova Z, Tanda G, Munzar P, Goldberg SR.
    Psychopharmacology (Berl); 2004 Apr 01; 173(1-2):186-94. PubMed ID: 14668977
    [Abstract] [Full Text] [Related]

  • 19. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
    Ilan AB, Gevins A, Coleman M, ElSohly MA, de Wit H.
    Behav Pharmacol; 2005 Sep 01; 16(5-6):487-96. PubMed ID: 16148455
    [Abstract] [Full Text] [Related]

  • 20. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.
    Chait LD, Zacny JP.
    Psychopharmacology (Berl); 1992 Sep 01; 107(2-3):255-62. PubMed ID: 1319601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.